← SynDRA
EPALRESTAT
SynDRA canonical compound SYN0002710 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | AKR1B1 |
| Mechanism of action | aldose reductase inhibitor |
| Indication | diabetic nephropathy |
| Disease area | nephrology |
All known targets
- AKR1B1
- AKR1A1
- AKR1B10
- Akr1a1
- Akr1b1
- CYP4A11
- SORD
Mechanisms of action (all sources)
- AKR1B1 INHIBITOR
- Aldose reductase inhibitor
Drug classes
Cross-references
Synonyms
- ONO-2235
- eabeth
- sorbistat
- kinedak
- Aldonil
- Aldorin
- Kinedak
- Tanglin
- Epalrestatum
- Ono-2235
- Epalrestat [INN]
- Epalrestatum [Latin]
- ONO 2
- 2-((z)-5-((e)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
- UNII-424DV0807X
- C15H13NO3S2
- CHEMBL56337
- 5-((1Z,2E)-2-Methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid
- CHEBI:31539
- 5-((Z,E)-beta-Methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid
- 424DV0807X
- Aldorin (TN)
- Kinedak (TN)
- Epalrestat (JAN/INN)
- {5-[(E)-2-Methyl-3-phenyl-prop-2-en-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid
- {(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid
- 2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
- 3-carboxymethyl-5-(methyl-3-phenylpropenylidene)rhodanine
- Ono 2235
- RefChem:590902
- DTXCID60210103
- MFCD00865484
- ONO2235
- Ropestatin;
- NCGC00164613-01
- Epalrestat (Standard)
- EPALRESTAT [MI]
- EPALRESTAT [JAN]
Look up EPALRESTAT in the interactive SynDRA portal →